Turning Point Therapeutics, Inc.

SOROS FUND MANAGEMENT LLC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/12/2022

Shares

821,635

Value ($000)

61,828

Weight

1.2%

2022 Q2 - 2022 Q2 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/12/2022	61,828	1.2%	821,635	6/30/2022